2023 Q3 Form 10-Q Financial Statement

#000147793223005817 Filed on August 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $290.0K $300.0K
YoY Change 10.74% 11.47%
Operating Profit -$287.5K -$300.8K
YoY Change 9.79% 11.76%
Interest Expense $950.0K $2.130M
YoY Change -2.39% 639.33%
% of Operating Profit
Other Income/Expense, Net $1.116M $3.722M
YoY Change 48.03% 112.52%
Pretax Income $830.0K $3.420M
YoY Change 68.6% 130.72%
Income Tax
% Of Pretax Income
Net Earnings $828.8K $3.421M
YoY Change 68.37% 130.82%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.14 $0.48
COMMON SHARES
Basic Shares Outstanding 7.129M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Cash & Equivalents $212.00 $212.00
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Inventory
Prepaid Expenses $19.29K $37.10K
Receivables
Other Receivables
Total Short-Term Assets $19.44K $37.32K
YoY Change -97.63% -96.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.500M $18.60M
YoY Change -97.06% -91.55%
Other Assets
YoY Change
Total Long-Term Assets $6.515M $18.60M
YoY Change -97.06% -91.55%
TOTAL ASSETS
Total Short-Term Assets $19.44K $37.32K
Total Long-Term Assets $6.515M $18.60M
Total Assets $6.534M $18.64M
YoY Change -97.06% -91.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $206.1K $52.90K
YoY Change 869.68% 10.2%
Deferred Revenue
YoY Change
Short-Term Debt $200.0K $100.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $430.2K $110.6K
YoY Change 263.51% -3.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000M $1.900M
YoY Change -90.65% -81.86%
Total Long-Term Liabilities $1.000M $1.900M
YoY Change -90.65% -81.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $430.2K $110.6K
Total Long-Term Liabilities $1.000M $1.900M
Total Liabilities $1.394M $2.027M
YoY Change -87.11% -80.86%
SHAREHOLDERS EQUITY
Retained Earnings -$1.900M -$2.465M
YoY Change -80.99% -74.09%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.375M -$1.940M
YoY Change
Total Liabilities & Shareholders Equity $6.534M $18.64M
YoY Change -97.06% -91.58%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $828.8K $3.421M
YoY Change 68.37% 130.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 -$150.0K
YoY Change -100.0% -27.82%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 0.000 -150.0K
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000
Net Change In Cash 0.000 -150.0K
YoY Change -100.0% -67.0%
FREE CASH FLOW
Cash From Operating Activities $0.00 -$150.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001848861
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41145
dei Entity Registrant Name
EntityRegistrantName
HEALTHCARE AI ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1585450
dei Entity Address Address Line1
EntityAddressAddressLine1
8 The Green
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 15614
dei Entity Address City Or Town
EntityAddressCityOrTown
Dover
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2464959 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8710675 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1940040 usd
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19810
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
446-0469
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7128726 shares
CY2023Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
18603504 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
223048887 usd
CY2022Q4 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
0 usd
CY2023Q2 us-gaap Assets
Assets
18640820 usd
CY2022Q4 us-gaap Assets
Assets
223672996 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52897 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28655 usd
CY2023Q2 haia Promissory Note Related Party
PromissoryNoteRelatedParty
50000 usd
CY2022Q4 haia Promissory Note Related Party
PromissoryNoteRelatedParty
0 usd
CY2023Q2 haia Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
7670 usd
CY2022Q4 haia Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
127095 usd
CY2023Q2 haia Over Allotment Liability
OverAllotmentLiability
0 usd
CY2022Q4 haia Over Allotment Liability
OverAllotmentLiability
0 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
110567 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
155750 usd
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1916789 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1314370 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
317285 usd
CY2023Q2 haia Deferred Underwriting Commisions
DeferredUnderwritingCommisions
0 usd
CY2022Q4 haia Deferred Underwriting Commisions
DeferredUnderwritingCommisions
7546840 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2027356 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9334245 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
18553504 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
223048887 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
524380 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2023Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 usd
CY2022Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8710136 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18640820 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
223672996 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
300773 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
269125 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
698705 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
692881 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-300773 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-269125 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-698705 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-692881 usd
CY2023Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
2134033 usd
CY2022Q2 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
288101 usd
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
4496872 usd
us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
301900 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1588197 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1463332 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-602419 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9419650 usd
CY2023Q2 haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
0 usd
CY2022Q2 haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
0 usd
haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
0 usd
haia Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
155881 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3722230 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1751433 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3894453 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9877431 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
3421457 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
1482308 usd
us-gaap Profit Loss
ProfitLoss
3195748 usd
us-gaap Profit Loss
ProfitLoss
9184550 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8710136 usd
CY2023Q1 haia Accretion Of Interest Earned On Trust Account To Common Stock Subject To Possible Redemption
AccretionOfInterestEarnedOnTrustAccountToCommonStockSubjectToPossibleRedemption
-2362839 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-225709 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-11298684 usd
CY2023Q2 haia Conversion Of Class B Shares To Class A Shares Amount
ConversionOfClassBSharesToClassASharesAmount
0 usd
CY2023Q2 haia Accretion Of Interest Earned On Trust Account To Common Stock Subject To Possible Redemption
AccretionOfInterestEarnedOnTrustAccountToCommonStockSubjectToPossibleRedemption
-2134033 usd
CY2023Q2 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
524380 usd
CY2023Q2 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
7546840 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3421457 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1940040 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18393982 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
7702242 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-10691740 usd
CY2022Q2 haia Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption
ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
-301900 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1482308 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9511332 usd
us-gaap Profit Loss
ProfitLoss
3195748 usd
us-gaap Profit Loss
ProfitLoss
9184550 usd
haia Formation Cost Paid By Sponsor
FormationCostPaidBySponsor
0 usd
haia Formation Cost Paid By Sponsor
FormationCostPaidBySponsor
0 usd
haia Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
-4496872 usd
haia Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
-301900 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-602419 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9419650 usd
haia Change In Overallotment Liability
ChangeInOverallotmentLiability
0 usd
haia Change In Overallotment Liability
ChangeInOverallotmentLiability
-155881 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
185730 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
266590 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24242 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1329113 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
57670 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
60000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
30000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
42000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-401063 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1653404 usd
haia Principal Deposited In Trust Account
PrincipalDepositedInTrustAccount
0 usd
haia Principal Deposited In Trust Account
PrincipalDepositedInTrustAccount
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-246766 usd
haia Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
0 usd
haia Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-246766 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-401063 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1900170 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401275 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2500000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
212 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
599830 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
36 usd
haia Accretion Of Interest Earned On Shares To Cssr
AccretionOfInterestEarnedOnSharesToCssr
4496872 usd
haia Accretion Of Interest Earned On Shares To Cssr
AccretionOfInterestEarnedOnSharesToCssr
301900 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
7546840 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
0 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
177095 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
0 usd
haia Deferred Offering Costs Assumed By Related Party Charge To Additiona Paid In Capital
DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionaPaidInCapital
347285 usd
haia Deferred Offering Costs Assumed By Related Party Charge To Additiona Paid In Capital
DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionaPaidInCapital
0 usd
haia Redemption Of Shares From Marketable Securities Held In Trust Account
RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount
208992255 usd
haia Redemption Of Shares From Marketable Securities Held In Trust Account
RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
2500000 usd
haia Threshold Minimum Aggregate Fair Market Value As Percentage Of Assets Held In Trust Account
ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetsHeldInTrustAccount
0.80 pure
haia Threshold Percentage Of Outstanding Voting Securities Of Target To Be Acquired By Post Transaction Company To Complete Business Combination
ThresholdPercentageOfOutstandingVotingSecuritiesOfTargetToBeAcquiredByPostTransactionCompanyToCompleteBusinessCombination
0.50 pure
haia Number Of Business Days To Redeem Shares Upon Completion Of Initial Business Combination
NumberOfBusinessDaysToRedeemSharesUponCompletionOfInitialBusinessCombination
two business days
CY2023Q2 us-gaap Share Price
SharePrice
10.20
CY2023Q2 haia Minimum Net Tangible Assets
MinimumNetTangibleAssets
5000001 usd
haia Threshold Period From Closing Of Initial Public Offering Company Is Obligated To Complete Business Combination
ThresholdPeriodFromClosingOfInitialPublicOfferingCompanyIsObligatedToCompleteBusinessCombination
P18M
haia Minimum Net Interest To Pay Dissolution Expenses
MinimumNetInterestToPayDissolutionExpenses
100000 usd
CY2023Q2 us-gaap Cash
Cash
212 usd
CY2022Q4 us-gaap Cash
Cash
401275 usd
CY2023Q2 haia Working Capital
WorkingCapital
73251 usd
CY2022Q4 haia Working Capital
WorkingCapital
468359 usd
CY2023Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
50000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 24.5pt; text-align:justify;">The preparation of financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 24.5pt; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 24.5pt; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q2 us-gaap Cash
Cash
212 usd
CY2022Q4 us-gaap Cash
Cash
401275 usd
CY2023Q2 haia Cash And Investments Held In Trust Account
CashAndInvestmentsHeldInTrustAccount
18603504 usd
CY2022Q4 haia Cash And Investments Held In Trust Account
CashAndInvestmentsHeldInTrustAccount
223048887 usd
us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
19824274 shares
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.54
CY2023Q2 us-gaap Amount Of Regulatory Costs Not Yet Approved
AmountOfRegulatoryCostsNotYetApproved
208992255 usd
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 24.5pt; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC Topic 825 “Financial Instruments,” offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.</p>
CY2023Q2 haia Dissolution Expense
DissolutionExpense
100000 usd
haia Founder Shares
FounderShares
1437500 shares
CY2023Q2 haia Accrued Sponsor Fees
AccruedSponsorFees
177095 usd
CY2022Q4 haia Accrued Sponsor Fees
AccruedSponsorFees
127095 usd
haia Cash Underwriting Discount Percentage
CashUnderwritingDiscountPercentage
0.02 pure
haia Underwriter Cash Discount
UnderwriterCashDiscount
4312480 usd
haia Deferred Underwriting Discount Percentage
DeferredUnderwritingDiscountPercentage
0.035 pure
haia Deferred Underwriter Discount Amount
DeferredUnderwriterDiscountAmount
7546840 usd
CY2023Q2 haia Deferred Underwriter Discount Amount
DeferredUnderwriterDiscountAmount
7546840 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
21906161 shares
CY2023Q2 haia Percentage Of Gross Proceeds On Equity Proceeds
PercentageOfGrossProceedsOnEquityProceeds
0.60 pure
CY2023Q2 haia Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price
ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice
1.15 pure
CY2023Q2 haia Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price One
ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPriceOne
1.80 pure
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Business Combination Acquired Receivables Gross Contractual Amount
BusinessCombinationAcquiredReceivablesGrossContractualAmount
50000 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5000001 usd
CY2023Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares
19824274 shares
CY2023Q2 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
208992255 usd
CY2023Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.54

Files In Submission

Name View Source Status
0001477932-23-005817-index-headers.html Edgar Link pending
0001477932-23-005817-index.html Edgar Link pending
0001477932-23-005817.txt Edgar Link pending
0001477932-23-005817-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
haia-20230630.xsd Edgar Link pending
haia_10q.htm Edgar Link pending
haia_ex311.htm Edgar Link pending
haia_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
haia-20230630_cal.xml Edgar Link unprocessable
haia-20230630_lab.xml Edgar Link unprocessable
haia-20230630_def.xml Edgar Link unprocessable
haia-20230630_pre.xml Edgar Link unprocessable
haia_10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending